19Dec 2024
Fast Screening Method Reveals Effective Antiviral Combinations for COVID-19

Fast Screening Method Reveals Effective Antiviral Combinations for COVID-19

The study presents a novel in vitro drug-sensitivity assay for SARS-CoV-2, evaluating antiviral combinations against ancestral and emerging variants, including Omicron strains. Monotherapies of remdesivir, nirmatrelvir, and EIDD-1931 demonstrated effective EC50s, but their efficacy varied across strains, particularly with nirmatrelvir. A strong synergy between remdesivir and nirmatrelvir was observed, with Bliss synergy scores >10 at clinically relevant concentrations. This method offers a fast, practical approach for identifying potent antiviral combinations and detecting resistance, supporting multi-drug strategies for enhanced COVID-19 treatment.

  • #oncology

Like

Save

Share